Nintedanib Interactions
There are 252 drugs known to interact with nintedanib, along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 18 are major, and 234 are moderate.
- View all 252 medications that may interact with nintedanib
- View nintedanib alcohol/food interactions (1)
- View nintedanib disease interactions (6)
Most frequently checked interactions
View interaction reports for nintedanib and the medicines listed below.
- Actemra (tocilizumab)
- Advair Diskus (fluticasone / salmeterol)
- Aleve (naproxen)
- Anoro Ellipta (umeclidinium / vilanterol)
- Breo Ellipta (fluticasone / vilanterol)
- Bumex (bumetanide)
- Claritin (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Diltiazem Hydrochloride SR (diltiazem)
- Dulera (formoterol / mometasone)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Glycerol (glycerin)
- Imodium (loperamide)
- Lipitor (atorvastatin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- Morphine Sulfate SR (morphine)
- Paracetamol (acetaminophen)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Sotalol Hydrochloride AF (sotalol)
- Symbicort (budesonide / formoterol)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Nintedanib alcohol/food interactions
There is 1 alcohol/food interaction with nintedanib.
Nintedanib disease interactions
There are 6 disease interactions with nintedanib which include:
- arterial thromboembolism
- bleeding
- gastrointestinal perforation
- hepatic impairment
- renal impairment
- smoking
Report options
More about nintedanib
- nintedanib consumer information
- Compare alternatives
- Reviews (36)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Ofev
Ofev (nintedanib) is used to treat a lung disease called idiopathic pulmonary fibrosis, and ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Esbriet
Esbriet ((pirfenidone) may be used to treat adults with idiopathic pulmonary fibrosis (IPF), a lung ...
Tofidence
Tofidence (tocilizumab-bavi) is administered as an intravenous infusion by a healthcare provider ...
Actimmune
Actimmune is used for chronic granulomatous disease, cutaneous t-cell lymphoma, idiopathic ...
Interferon gamma-1b
Interferon gamma-1b systemic is used for chronic granulomatous disease, cutaneous t-cell lymphoma ...
Pirfenidone
Pirfenidone information from Drugs.com, includes Pirfenidone side effects, interactions and indications.
Tocilizumab
Tocilizumab systemic is used for COVID-19, cytokine release syndrome, giant cell arteritis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
